Magnetic Millirobots for Region-Specific Drug Delivery in the Rat Central Nervous System
JoVE Encyclopedia of Experiments
Neuroscience
0 views • 1:20 min • August 7th, 2025
Begin with a harvested rat brain submerged in artificial cerebrospinal fluid in a petri dish.
Deposit the magnetic millirobot onto the brain cortex.
The millirobot, termed MANiAC, consists of magnetically aligned nickel nanorods embedded within a microcapsule composed of the biocompatible hydrogel alginate and loaded with a dye as a model drug.
Position an external magnetic field generator beneath the petri dish to generate a uniform rotating magnetic field.
The nickel nanorods align and rotate with the magnetic field, propelling the MANiAC over the cortical surface.
Allow the MANiAC to traverse the cortical surface, pausing at target sites for controlled drug release.
The drug diffuses through the alginate capsule into the brain’s extracellular matrix, reaching neurons and glial cells.
The cells uptake the drug molecules via receptor-mediated endocytosis.
The run-and-pause motion ensures localized drug deposition while minimizing off-target delivery, and allows for redosing at previously treated sites.
Overview
This study presents the use of a magnetic millirobot, MANiAC, for targeted drug delivery in a harvested rat brain. The millirobot, composed of nickel nanorods and a biocompatible hydrogel, facilitates localized drug release while minimizing off-target effects.
Key Study Components
Area of Science
- Neuroscience
- Drug Delivery Systems
- Biomedical Engineering
Background
- Targeted drug delivery is crucial for effective treatment in neurological disorders.
- Magnetic millirobots can navigate biological tissues using external magnetic fields.
- Controlled drug release mechanisms enhance therapeutic efficacy.
- Utilizing biocompatible materials is essential for safety in biological applications.
Purpose of Study
- To demonstrate the efficacy of MANiAC in delivering drugs to specific brain regions.
- To evaluate the precision of drug release using a run-and-pause motion strategy.
- To assess the uptake of drugs by neurons and glial cells.
Methods Used
- Harvesting rat brains and submerging them in artificial cerebrospinal fluid.
- Depositing the MANiAC millirobot onto the cortical surface.
- Employing an external magnetic field generator to control the millirobot's movement.
- Monitoring drug diffusion from the alginate capsule into the extracellular matrix.
Main Results
- MANiAC effectively navigated the cortical surface and paused at target sites.
- Localized drug release was achieved with minimal off-target delivery.
- Neurons and glial cells successfully uptook the released drug molecules.
- The run-and-pause motion allowed for redosing at previously treated sites.
Conclusions
- The magnetic millirobot MANiAC shows promise for targeted drug delivery in neuroscience.
- Controlled drug release can enhance therapeutic outcomes in brain treatments.
- Further studies are needed to optimize the system for clinical applications.
Frequently Asked Questions
Executive Industry Relevance
Magnetic millirobots such as MANiAC enable region-specific drug delivery within the central nervous system, addressing the challenge of precise therapeutic targeting in complex neural tissues. This approach supports predictive confidence in early-stage CNS drug discovery by minimizing off-target exposure and enabling localized dosing. The technology is positioned to impact portfolio decisions where spatial precision and controlled release are critical for translational success.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables interrogation of region-specific drug effects in ex vivo neural tissue.
- Supports biological de-risking by isolating drug action to defined brain areas.
- Facilitates functional target validation through localized delivery and uptake assessment.
Screening & Assay Development
- Prepares validated neural tissue systems for downstream pharmacological screening.
- Standardizes spatially controlled dosing for reproducible quantitative outputs.
- Enables reliable evaluation of compound uptake by neurons and glial cells.
Translational & Preclinical Research
- Aligns with disease-relevant CNS models for translational biomarker studies.
- Supports continuity from discovery to preclinical validation by enabling redosing and spatially resolved delivery.
- Provides predictive de-risking for CNS-targeted therapeutics by minimizing off-target effects.
Pipeline & Workflow Integration
This method integrates into the discovery-to-preclinical continuum for CNS drug candidates, supporting both mechanistic studies and translational research.
- Discovery Biology: Facilitates hypothesis testing on spatially restricted drug effects in neural tissue.
- Screening: Delivers reproducible, quantitative readouts of drug uptake and distribution.
- Analytics: Provides measurable outputs for comparing localized versus diffuse delivery strategies.
- Translational Research: Bridges early discovery with preclinical CNS models through region-specific dosing.
- Enterprise Reuse: Offers a reusable platform for spatially targeted delivery studies across multiple CNS targets.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in CNS drug delivery.
- Operational Value: Standardizes spatial dosing and supports reproducibility in neural tissue assays.
- Strategic Value: Improves go/no-go decisions for CNS assets by enabling precise delivery and redosing.
- Portfolio Impact: Supports risk-adjusted prioritization of CNS candidates with spatially defined mechanisms.
Implementation Considerations
- Requires expertise in neural tissue handling and magnetic field manipulation.
- Needs access to external magnetic field generators and imaging infrastructure.
- Demands cross-team standardization for reproducible region-specific delivery.
- May require adaptation for different brain regions or model systems.
- Limited to ex vivo applications as described; in vivo translation requires further development.
Biopharma FAQs
Magnetic and Thermal-sensitive Poly(N-isopropylacrylamide)-based Microgels for Magnetically Triggered Controlled Release
Related Videos
0 Views
Protocol for MicroRNA Transfer into Adult Bone Marrow-derived Hematopoietic Stem Cells to Enable Cell Engineering Combined with Magnetic Targeting
Related Videos
0 Views
Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy
Related Videos
0 Views
Systemic and Local Drug Delivery for Treating Diseases of the Central Nervous System in Rodent Models
Related Videos
0 Views
Microinjection-Based Delivery of a Therapeutic Agent into an Awake Rodent Brain
Related Videos
0 Views
Drug Microinjection with Electrophysiological Recording in a Rat Brain
Related Videos
0 Views
Direct Intraventricular Delivery of Drugs to the Rodent Central Nervous System
Related Videos
0 Views
Rodent Brain Microinjection to Study Molecular Substrates of Motivated Behavior
Related Videos
0 Views
PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator
Related Videos
0 Views
A Positioning Device for the Placement of Mice During Intranasal siRNA Delivery to the Central Nervous System
Related Videos
0 Views
Last updated: 29 August 2026